FGFR1 is amplified during the progression of in situto invasive breast carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
FGFR1 is amplified during the progression of in situto invasive breast carcinoma ; volume:14 ; number:4 ; day:3 ; month:8 ; year:2012 ; pages:1-12 ; date:8.2012
Breast cancer research ; 14, Heft 4 (3.8.2012), 1-12, 8.2012
- Urheber
-
Jang, Min Hye
- Beteiligte Personen und Organisationen
-
Kim, Eun Joo
Choi, Yoomi
Lee, Hee Eun
Kim, Yu Jung
Kim, Jee Hyun
Kang, Eunyoung
Kim, Sŭng-wŏn
Kim, In Ah
Park, So Yeon
SpringerLink (Online service)
- DOI
-
10.1186/bcr3239
- URN
-
urn:nbn:de:1111-2016032415404
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jang, Min Hye
- Kim, Eun Joo
- Choi, Yoomi
- Lee, Hee Eun
- Kim, Yu Jung
- Kim, Jee Hyun
- Kang, Eunyoung
- Kim, Sŭng-wŏn
- Kim, In Ah
- Park, So Yeon
- SpringerLink (Online service)
Ähnliche Objekte (12)
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
FGFR1 and WT1 are markers of human prostate cancer progression
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer
Amplified imagination
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
FGFR1-Expression und Genkopienanzahl beim Lungenkarzinom
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
FGFR1 and WT1 are markers of human prostate cancer progression
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer
Amplified imagination
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
FGFR1-Expression und Genkopienanzahl beim Lungenkarzinom
Activating FGFR1 Mutations in Sporadic Pheochromocytomas
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial–mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
FGFR1 and WT1 are markers of human prostate cancer progression
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancer
Amplified imagination
Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression
MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing
Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma
FGFR1-Expression und Genkopienanzahl beim Lungenkarzinom